Cerebrospinal Fluid Biomarker Could Help Identify Early Alzheimer’s Disease

Cerebrospinal Fluid Biomarker Could Help Identify Early Alzheimer’s Disease
A new study out of Michigan points to the pro nerve growth factor (proNGF) as a possible biomarker that could aid in the diagnosis of early Alzheimer’s disease (AD). The article, “Cerebrospinal fluid proNGF: A putative biomarker for early Alzheimer’s disease,“ appeared in the journal Current Alzheimer’s Research. AD is a degenerative neurological condition in which

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *